Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:28 PM
Ignite Modification Date:
2025-12-24 @ 11:28 PM
NCT ID:
NCT04629456
Eligibility Criteria:
Inclusion Criteria:
* Positive for anti-HCV.
* Not under antiviral therapy at entry.
* Positive for chronic hepatitis or compensated cirrhosis.
* Negative for hepatitis B surface (HBs) antigen.
* Free of co-infection with HIV.
* Not pregnant.
* Systolic blood pressure of less than 180 mmHg or diastolic blood pressure of less than 110 mmHg.
* (viii)No ischemic heart disease or severe arrhythmia
Exclusion Criteria:
* Significant cardiac disease (ejection fraction \<60% or history of coronary artery disease).
* Chronic renal failure on dialysis.
* Hemoglobin \<11.0 g/L.
* Human immunodeficiency virus infection.
* Hepatocellular carcinoma.
* Active non-hepatocellular carcinoma related malignancy.
* Myopathy.
* Any physical impairment or orthopedic abnormality preventing EX, or post-liver transplantation
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
35 Years
Maximum Age:
59 Years
Study:
NCT04629456
Study Brief:
Protocol Section:
NCT04629456